The drug cemiplimab is being studied for cervical cancer Many women diagnosed with recurrent cervical cancer often face poor prognosis, but cemiplimab, a current treatment for lung and skin cancers, shows promising activity in cervical cancers that have spread..
Each year, roughly 600,000 women are diagnosed with new cases of cervical cancer, accompanied by 350,000 deaths worldwide. In the United…